Find My Path Contact
L · Light — Aesthetics
LightStim Red Light Red Light Therapy IPL + Facials TriLift Facial Sculpting RF Microneedling Geneo OxyGeneo
E² · Energy — Cellular
PEMF Therapy NAD+ & Peptides
O · Oxygen — Recovery
Hyperbaric Oxygen (HBOT) HBOT for Athletes HBOT Trial $199 HBOT Cost Guide 10-Pass Ozone
N · Nutrition — Metabolic
GLP-1 Weight Loss GLP-1 Cost Guide Styku 3D Body Scan
E² · Exercise — Performance
Rescu Performance — The Floor Train with Myrna Brady Emsculpt Neo Emsella Vanquish ME Shockwave Therapy
Who We Help
Conditions We Support Beauty & Aging Pickleball Players Executives & Longevity Pain & Injury Post-Surgery Recovery Cancer Support Men's Health
Pathways Bundles Compare Results About
Book Consultation Call 914-401-8552 WhatsApp
Hyperbaric oxygen chamber at Rescu Wellness, a physician-owned medical practice in Scarsdale NY

PARENT EDUCATION · PHYSICIAN-REVIEWED · SCARSDALE NY

HBOT + AUTISM.
THE STRAIGHT ANSWER.

If you're a parent researching hyperbaric oxygen therapy for your child, you've probably seen bold claims online. Here's a plain-language summary from a physician-owned practice — including the studies that don't flatter the sale.

EDUCATIONAL CONTENT NOT A CURE NOT A REPLACEMENT FOR STANDARD THERAPY CONSULT-FIRST ONLY
Book a parent pre-consult → 914-401-8552

01 · THE HYPOTHESIS

WHY PARENTS
EXPLORE HBOT.

Researchers have studied HBOT as a possible supportive option because some autism research has looked at inflammation, oxidative stress, and cerebral blood-flow differences in some children. HBOT delivers oxygen-rich air under gentle pressure, and the scientific question has been whether that may support brain and body function in a subset of children.

Two words matter here: research hypothesis. This is a question scientists have investigated — not a proven mechanism, and not a cure. Families who explore it generally frame it as a possible supportive therapy alongside a child's established care, never in place of it.

Why parents explore HBOT — researchers have studied inflammation, oxidative stress, and blood-flow differences; a research hypothesis, not proof
Research hypothesis — not proof
What HBOT involves — in autism studies, commonly 1.3 ATA with 24% oxygen, about 40 sessions of 60 minutes, with screening and supervision
Study parameters — individualized in practice

02 · WHAT THE STUDIES USED

WHAT HBOT
INVOLVES.

In the published autism studies, HBOT was typically delivered at a mild pressure of 1.3 ATA with 24% oxygen — noticeably gentler than the pressures used for FDA-cleared medical indications. The most-cited controlled trial used 40 sessions of about 60 minutes each, with the child relaxing inside the chamber while monitored by trained staff.

Those are study parameters, not a menu item. If HBOT were ever considered for a specific child, the approach would need to be individualized by a physician after screening — which is exactly why this page ends at a consult, not a checkout.

03 · THE ENCOURAGING SIGNAL

WHAT SOME
STUDIES FOUND.

A 2009 multicenter, randomized, controlled trial (Rossignol et al.) reported improvements after 40 sessions in areas including overall functioning, receptive language, social interaction and eye contact, and sensory awareness. Some later reviews and pooled analyses — including a 2025 meta-analysis of 17 studies — have also reported possible gains in communication and behavior.

The critical caveat
A 2010 randomized, sham-controlled trial designed to replicate the 2009 results could not: children receiving HBOT did no better than children receiving placebo. And the positive 2025 pooled analysis mixed rigorous trials with lower-quality study designs. An encouraging signal in some studies is not the same as replicated, established evidence — and any provider who quotes you only the 2009 trial is telling you half the story.
What some studies found — a 2009 randomized controlled trial reported improvement after 40 sessions in several areas; an encouraging signal, not definitive proof
Encouraging signal — not definitive proof
The big reality check — HBOT for autism remains controversial because the overall evidence is mixed; promising for some, not established for all
Promising for some — not established for all

04 · THE FULL PICTURE

THE BIG
REALITY CHECK.

Here is the part many clinics skip. Cochrane's 2016 systematic review — medicine's most demanding standard of evidence synthesis — found no evidence that HBOT improves core or associated symptoms of ASD. A separate 2016 evidence-based review reached the same conclusion, and a 2012 review of the randomized trials noted that the promising early effects were not replicated.

The FDA has not cleared HBOT for autism, and has publicly cautioned families about clinics marketing hyperbaric therapy for conditions where it is unproven. Mainstream autism-care guidelines do not recommend it. That means parents should weigh any potential upside against real cost, real time, and genuine scientific uncertainty.

Why we tell you this
We're a physician-owned medical practice, and we'd rather lose a sale than earn one on half the evidence. Informed parents make better decisions — and if the science changes, this page will change with it.

05 · IF YOU'RE STILL CONSIDERING IT

SAFETY +
SCREENING.

At the mild pressures used in the studies, supervised HBOT is generally well tolerated — but "generally" is doing work in that sentence, and children are not small adults. Before any session would ever be considered, a physician needs to screen carefully:

1
Ears, sinuses & pressure clearing
Ear or sinus congestion and a child's ability to equalize pressure are the most common practical issues — and a hard stop if unresolved.
2
Seizure history & medications
Seizure history and current medications need physician review before pressure and elevated oxygen are ever introduced.
3
Anxiety & claustrophobia
A chamber should feel calm, not distressing. If enclosure is frightening for a child, that matters more than any protocol.
4
Supervision & role
HBOT should be supervised by trained staff and considered only as a possible complement — never a replacement — for a child's established therapies and standard of care.
Safety and next steps — before HBOT a child should be screened carefully: ears and sinuses, seizure history, anxiety, medications, and ability to clear pressure
Screening first — always

WHERE RESCU STANDS

A CONVERSATION.
NOT A CHECKOUT.

We do not market HBOT as a treatment for autism, and we won't sell you forty dives on hope. If, after reading all of this, you're still weighing HBOT for your child, the right first step is a parent pre-consult with Dr. Taylor — a board-certified emergency physician and the owner of this practice.

He'll review your child's health history and current therapies, walk through the evidence honestly, screen for the safety considerations above, and give you a straight answer about whether your child would even be an appropriate candidate. Sometimes that answer is no — and you'll hear it plainly before anyone books anything.

Book a parent pre-consult → Call 914-401-8552 WhatsApp

EDUCATIONAL CONTENT · NOT MEDICAL ADVICE · HBOT IS NOT FDA-CLEARED FOR AUTISM · NOT INTENDED TO DIAGNOSE, TREAT, CURE, OR PREVENT ANY DISEASE

RESCU/FAQ · PARENTS' QUESTIONS, ANSWERED STRAIGHT

What parents ask.

Is HBOT an FDA-approved treatment for autism?
No. The FDA has not cleared or approved hyperbaric oxygen therapy for autism, and it has publicly cautioned consumers about clinics that market HBOT as a treatment for conditions where it isn't proven. Any provider presenting HBOT as an established autism treatment is ahead of the evidence.
Does HBOT cure autism?
No. Autism is not a disease to be cured, and no therapy — HBOT included — changes that. The research question scientists have studied is narrower: whether HBOT may support certain functions in some children. That question remains unsettled.
What does the research actually show?
Mixed results. A 2009 randomized controlled trial reported improvements in several areas after 40 sessions. A 2010 randomized, sham-controlled trial designed to replicate those results found no difference between HBOT and placebo. Cochrane's 2016 systematic review found no evidence that HBOT improves core or associated ASD symptoms. A 2025 meta-analysis pooling 17 studies reported positive effects, but it included lower-quality study designs alongside trials. Encouraging signal — not established treatment.
Is HBOT safe for children?
In supervised settings with proper screening, HBOT at the mild pressures used in autism studies is generally well tolerated, with ear-pressure discomfort the most common issue. Screening matters: ear and sinus health, seizure history, anxiety or claustrophobia, medications, and a child's ability to equalize pressure all need physician review first.
What happens at a parent pre-consult?
A conversation with the physician — not a sales pitch. Dr. Taylor reviews your child's health history and current therapies, walks through what the evidence does and doesn't show, screens for safety, and gives you a straight answer about whether your child would even be an appropriate candidate. Sometimes that answer is no, and you'll hear it before anyone books anything.

Sources & further reading

  1. Rossignol DA, et al. Hyperbaric treatment for children with autism: a multicenter, randomized, double-blind, controlled trial. BMC Pediatrics. 2009.
  2. Granpeesheh D, et al. Randomized trial of hyperbaric oxygen therapy for children with autism. Research in Autism Spectrum Disorders. 2010.
  3. Ghanizadeh A. Hyperbaric oxygen therapy for treatment of children with autism: a systematic review of randomized trials. Medical Gas Research. 2012.
  4. Xiong T, et al. Hyperbaric oxygen therapy for people with autism spectrum disorder (ASD). Cochrane Database of Systematic Reviews. 2016.
  5. Goldfarb C, et al. Hyperbaric oxygen therapy for the treatment of children and youth with Autism Spectrum Disorders: an evidence-based systematic review. Research in Autism Spectrum Disorders. 2016.
  6. Systematic review and meta-analysis of HBOT in children and adolescents with autism spectrum disorders (17 studies, 890 patients). Progress in Neuro-Psychopharmacology & Biological Psychiatry. 2025.
  7. U.S. Food & Drug Administration. Hyperbaric Oxygen Therapy: Get the Facts. FDA Consumer Update.